• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SDX
Click for more information
0.00% 6.2¢

SIENNA CANCER DIAGNOSTICS LIMITED

Currently unlisted. Proposed listing date: 3 AUGUST 2017 11:00AM AEST watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SDX
News: SDX Sienna Cancer Diagnostics Appoints Inside Diagnósticos As Exclusive Distribution Partner... 		18/03/19 0 198
18/03/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  198 
SDX
Ann: Sienna Appoints Exclusive Distribution Partner for Brazil 		18/03/19 0 242
18/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  242 
SDX
Ann: CEO Interview - March 2019 		13/03/19 0 153
13/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  153 
SDX
Ann: Furthers Global Expansion with Distributor for Singapore 		23/02/19 4 901
23/02/19 Last post  Ozibobby Comments Created with Sketch.  4  Views Created with Sketch.  901 
SDX
News: SDX Sienna Cancer Diagnostics Appoints Mediwell Enterprise As Distribution Partner For... 		04/02/19 0 66
04/02/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  66 
SDX
Ann: Appendix 4D and Half-year financial report 		31/01/19 0 97
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  97 
SDX
Ann: Appendix 4C - quarterly 		31/01/19 0 83
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  83 
SDX
News: SDX Sienna Cancer Diagnostics Signs Deal With Mirax Corporation 		23/01/19 1 284
23/01/19 Last post  beefarmer Comments Created with Sketch.  1  Views Created with Sketch.  284 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.